Decrease in the incidence of mupirocin resistance among methicillin-resistant Staphylococcus aureus in carriers from an intensive care unit

被引:10
|
作者
Caierao, J
Berquó, L
Dias, C
d'Azevedo, PA
机构
[1] Fdn Fac Fed Ciencias Med Porto Alegre, BR-90050170 Porto Alegre, RS, Brazil
[2] Hosp Mae de Deus, Porto Alegre, RS, Brazil
关键词
D O I
10.1016/j.ajic.2005.08.006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a serious nosocomial problem, globally distributed. Decolonization with mupirocin can be used to control its dissemination. Objective: To determine the incidence of mupirocin resistance among MRSA carriers from an intensive care unit. Methods: We obtained 2723 nasal swabs during 3 years. Resistance to methicillin and mupirocin were verified (agar diffusion and the E test) and confirmed by polymerase chain reaction (PCR) (mecA for methicillin; ReS-2 and mupA for mupirocin). Plasmid-curing procedure and pulsed-held gel electrophoresis (PFGE) were employed in isolates exhibiting high resistance to mupirocin (HR-Mup) and in other selected organisms. Results: The overall incidence of HR-Mup among MRSA carriers during the studied period was 4.84% (8/165); however, the incidence decreased from 13.04% (6/46) in the first year to 3.5% (2/57) in the second year and was 0% in the last year (P = .02). LR-Mup, in contrast, increased significantly (P = .01). Conclusion: Plasmid-curing procedure showed the plasmid location of genes responsible for HR-Mup. PFGE demonstrated that most MRSA, including the isolates with HR-Mup, were genetically related, The decline in HR-Mup may be attributable to the plasmid location of genes (ileS-2/mupA) and to the fact that all patients colonized with HR-Mup MRSA died or were discharged in a relatively short period of time.
引用
收藏
页码:6 / 9
页数:4
相关论文
共 50 条
  • [21] Control of methicillin-resistant Staphylococcus aureus outbreak in an intensive care unit
    Willke, A
    Dundar, V
    Gundes, S
    Meric, M
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S124 - S125
  • [22] Mupirocin-resistant methicillin-resistant Staphylococcus aureus
    Ambler, JE
    Drabu, YJ
    JOURNAL OF HOSPITAL INFECTION, 1996, 32 (01) : 71 - 72
  • [23] Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit:: Role of treatment with Mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA
    Sandri, Ana Maria
    Dalarosa, Micheline Gisele
    de Alcantara, Luciana Ruschel
    Elias, Laura da Silva
    Zavascki, Alexandre Prehn
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2006, 27 (02): : 185 - 187
  • [24] Community-genotype strains of methicillin-resistant Staphylococcus aureus with high-level mupirocin resistance in a neonatal intensive care unit
    Park, So-Hyun
    Kim, Soo-Young
    Lee, Jung-Hyun
    Park, Chulmin
    Lee, Dong-Gun
    EARLY HUMAN DEVELOPMENT, 2013, 89 (09) : 661 - 665
  • [25] The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a veterans' affairs hospital
    Vasquez, JE
    Walker, ES
    Franzus, BW
    Overbay, BK
    Reagan, DR
    Sarubbi, FA
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2000, 21 (07): : 459 - 464
  • [26] High-level mupirocin resistance among Spanish methicillin-resistant Staphylococcus aureus
    Alarcón, T
    Sanz, JC
    Blanco, F
    Domingo, D
    López-Brea, M
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (12) : 877 - 879
  • [27] High-Level Mupirocin Resistance among Spanish Methicillin-Resistant Staphylococcus aureus
    T. Alarcón
    J. C. Sanz
    F. Blanco
    D. Domingo
    M. López-Brea
    European Journal of Clinical Microbiology and Infectious Diseases, 1998, 17 : 877 - 879
  • [28] Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units
    Arno Muller
    Daniel Talon
    Alexandre Potier
    Evelyne Belle
    Gilles Cappelier
    Xavier Bertrand
    Critical Care, 9
  • [29] Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units
    Muller, A
    Talon, D
    Potier, A
    Belle, E
    Cappelier, G
    Bertrand, X
    CRITICAL CARE, 2005, 9 (03): : R246 - R250
  • [30] NASOPHARYNGEAL COLONIZATION WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AND MORTALITY AMONG PATIENTS IN AN INTENSIVE CARE UNIT
    Fortaleza, Cristiane Ravagnani
    de Melo, Edson Carvalho
    Castelo Branco Fortaleza, Carlos Magno
    REVISTA LATINO-AMERICANA DE ENFERMAGEM, 2009, 17 (05): : 677 - 682